| 25-6287 |
Marcus Brent Fields v. Pfizer Inc., et al. |
Second Circuit |
2025-12-04 |
Pending |
corporate-ethics drug-development federal-violations pharmaceutical-liability regulatory-compliance securities-law |
a) Pfizer Defendands Knew there Courd ~ TO yotene Lot RA boy ,
Could ~ Cause more Sever and or Heard damage body orguns damage
eS pecially Ceeapmet Am… |
| 20-74 |
Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office v. Eugene H. Luoma, et al. |
Federal Circuit |
2020-07-27 |
GVR |
administrative-law america-invents-act enablement intellectual-property judicial-review obviousness patent-eligibility patent-review patent-trial-and-appeal-board patent-validity prior-art written-description |
Whether the Patent Trial and Appeal Board's application of the statutory requirements for patentability under 35 U.S.C. §§ 101, 102, 103, and 112 was … |
| 19-278 |
Pfizer Inc., et al. v. Superior Court of California, County of Los Angeles, et al. |
California |
2019-09-03 |
Denied |
bristol-myers-squibb civil-procedure due-process federal-courts federal-law forfeiture jurisdiction personal-jurisdiction subject-matter-jurisdiction |
Whether a defendant's efforts to establish federal subject matter jurisdiction can result in forfeiture of an otherwise fully preserved challenge to p… |